Point72 Hong Kong LTD Eiger Bio Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

  • $1.96 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.99 - $8.96 $1,716 - $3,082
-344 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$3.84 - $9.74 $6,462 - $16,392
-1,683 Reduced 83.03%
344 $3,000
Q4 2021

Feb 14, 2022
BUY
$5.12 - $8.19 $10,378 - $16,601
2,027 New
2,027 $11,000
Q2 2020

Aug 14, 2020
SELL
$5.4 - $13.37 $13,429 - $33,251
-2,487 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$4.91 - $14.7 $12,211 - $36,558
2,487 New
2,487 $17,000

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $496M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email